drugset / Trial / NCT02455440

Esmolol Infusion in Patients Undergoing Craniotomy

NCT02455440

Phase 3 Completed 50 enrolled George Papanicolaou Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

Anesthesia techniques that minimize anesthetic requirements and their effects may be beneficial. Esmolol, a short acting hyperselective β-adrenergic blocker is effective in blunting adrenergic response to several perioperative stimuli and so it might interfere in the effect of the anesthetic drugs on the brain. This study was designed to investigate the effect of esmolol on the consumption of propofol and sevoflurane in patients undergoing craniotomy.

Timeline

Start
2014-03
Primary completion
2015-07
Completion
2015-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Esmolol Other / unclassified 200 ug/kg
Comparator Propofol Small molecule
Comparator Sevoflurane Other / unclassified

Indications